A Normal Health Check Can Miss Years of Metabolic Damage | Opinion
Summary
Routine measures such as blood pressure, glucose, HbA1c, and cholesterol show current health but may not reflect years of metabolic stress. Research links skin autofluorescence, a measure associated with tissue buildup of advanced glycation end-products, to higher cardiovascular and mortality risks, though its value for guiding individual care remains unclear.Key Facts
- Advanced glycation end-products form when sugars react with proteins or fats and can accumulate in body tissues over time.
- A 2026 meta-analysis found that higher skin autofluorescence was associated with increased risks of cardiovascular events, cardiovascular death, stroke, and death from any cause.
- The meta-analysis authors said more research is needed to determine whether skin autofluorescence improves existing risk scores and how clinicians should use it.
- An association between a measure and health outcomes does not prove that the measure can predict an individual’s future.
- The American Heart Association’s 2026 statistics report says cardiovascular disease and stroke together accounted for more than one-quarter of U.S. deaths in 2023.
- When test results and a patient’s history suggest different levels of risk, clinicians can investigate the discrepancy, refer the patient when appropriate, and reconsider prevention or treatment plans.
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.